NASDAQ:GILD - Gilead Sciences Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $62.80 -0.24 (-0.38 %) (As of 04/24/2019 04:00 PM ET)Previous Close$63.04Today's Range$62.20 - $63.1952-Week Range$60.32 - $79.61Volume5.40 million shsAverage Volume7.45 million shsMarket Capitalization$80.06 billionP/E Ratio10.21Dividend Yield4.00%Beta1.16 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Gilead Sciences (NASDAQ:GILD) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.19 Wall Street analysts have issued ratings and price targets for Gilead Sciences in the last 12 months. Their average twelve-month price target is $81.9375, suggesting that the stock has a possible upside of 30.47%. The high price target for GILD is $95.00 and the low price target for GILD is $68.00. There are currently 7 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.632.632.622.53Ratings Breakdown: 0 Sell Rating(s)7 Hold Rating(s)12 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)8 Hold Rating(s)10 Buy Rating(s)1 Strong Buy Rating(s)0 Sell Rating(s)8 Hold Rating(s)13 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)10 Hold Rating(s)8 Buy Rating(s)1 Strong Buy Rating(s)Consensus Price Target: $81.9375$82.0625$88.3684$87.7512Price Target Upside: 30.47% upside28.69% upside33.87% upside28.05% upsideGilead Sciences (NASDAQ:GILD) Consensus Price Target History Gilead Sciences (NASDAQ:GILD) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails4/23/2019Raymond JamesSet Price TargetBuy$86.00Low4/22/2019OppenheimerSet Price TargetBuy$85.00Low4/22/2019MizuhoSet Price TargetBuy$88.00Low4/10/2019UBS GroupUpgradeNeutral ➝ Buy$75.00 ➝ $77.00Low3/29/2019Maxim GroupReiterated RatingBuy$84.00Medium3/14/2019BMO Capital MarketsInitiated CoverageOutperform$78.00Medium3/7/2019Piper Jaffray CompaniesSet Price TargetHold$75.00Medium3/7/2019JPMorgan Chase & Co.Reiterated RatingBuyLow2/12/2019CitigroupDowngradeBuy ➝ Neutral$100.00 ➝ $75.00Medium2/11/2019Wells Fargo & CoDowngradeOutperform ➝ Market Perform$95.00 ➝ $68.00Medium1/3/2019CIBCUpgradeMarket Perform ➝ Outperform$85.00Low12/19/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$85.00 ➝ $86.00Medium12/19/2018Cantor FitzgeraldReiterated RatingOverweight$92.00Medium12/17/2018GuggenheimInitiated CoverageBuy$86.00Low11/14/2018Needham & Company LLCReiterated RatingHoldMedium10/31/2018Evercore ISIReiterated RatingBuyMedium10/26/2018BarclaysBoost Price TargetOverweight ➝ Overweight$90.00 ➝ $95.00Medium7/26/2018Robert W. BairdDowngradeOutperform ➝ Neutral$79.00High5/2/2018Leerink SwannSet Price TargetMarket Perform$80.00 ➝ $72.00High4/17/2018Credit Suisse GroupSet Price TargetHold$80.00Low2/23/2018Royal Bank of CanadaReiterated RatingBuy$94.00Low2/7/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$82.00 ➝ $87.00Medium1/26/2018Jefferies Financial GroupUpgradeHold ➝ Buy$81.19 ➝ $93.00High11/13/2017ArgusDowngradeBuy ➝ Hold$73.25 ➝ $73.77N/A10/19/2017William BlairReiterated RatingBuyN/A10/19/2017Berenberg BankSet Price TargetBuy$96.00N/A8/31/2017CowenReiterated RatingOutperform$90.00Medium8/31/2017Deutsche BankReiterated RatingBuy$81.00Medium7/26/2017Redburn PartnersInitiated CoverageBuyMedium5/3/2017GabelliReiterated RatingBuy$85.00Medium5/3/2017Stifel NicolausReiterated RatingBuy$87.00Medium(Data available from 4/24/2017 forward) This page was last updated on 4/24/2019 by MarketBeat.com StaffFeatured Article: What is diluted earnings per share (Diluted EPS)?